reDucing the health and Economic COst of Diagnostic uncErtainty: establishing potential applications of BV™ and its composite biomarkers in COVID-19 detection and patient management

Risultati finali

Peer-reviewed publication about applicability of MeMed BV™ for serum on Key™ to COVID-19 patient management

Peerreviewed publication about applicability of MeMed BV for serum on Key to COVID19 patient management

Pubblicazioni

Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19

Autori: Shaul Lev, Tamar Gottesman, Gal Sahaf Levin, Doron Lederfein, Evgeny Berkov, Dror Diker, Aliza Zaidman, Amir Nutman, Tahel Ilan Ber, Alon Angel, Lior Kellerman, Eran Barash, Roy Navon, Olga Boico, Yael Israeli, Michal Rosenberg, Amir Gelman, Roy Kalfon, Einav Simon, Noa Avni, Mary Hainrichson, Oren Zarchin, Tanya M. Gottlieb, Kfir Oved, Eran Eden, Boaz Tadmor
Pubblicato in: PLOS ONE, Numero 16/1, 2021, Pagina/e e0245296, ISSN 1932-6203
Editore: Public Library of Science
DOI: 10.1371/journal.pone.0245296

An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcome

Autori: Niv Samuel Mastboim, Alon Angel, Oded Shaham, Tahel Ilan Ber, Roy Navon, Einav Simon, Michal Rosenberg, Yael Israeli, Mary Hainrichson, Noa Avni, Eran Reiner, Paul Feigin, Kfir Oved, Boaz Tadmor, Pierre Singer, Ilya Kagan, Shaul Lev, Dror Diker, Amir Jarjou’i, Ramzi Kurd, Eli Ben-Chetrit, Guy Danziger, Cihan Papan, Sergey Motov, Ma’anit Shapira, Michal Stein, Adi Klein, Tanya M Gottlieb, Eran
Pubblicato in: medRxiv, 2021, ISSN 0000-0000
Editore: CSHL
DOI: 10.1101/2021.06.27.21259196

Risultati finali

Pubblicazioni

Condividi questa pagina

Scarica